Catalyst Wire Dossier Catalyst Wire Dossier

SION-109

· Sionna Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SION-109, covering 2025-09-03 to 2025-09-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants. [Phase 1]

See pricing